Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chan-Loi Yong, Joseph C. Gathe, Gabriele Knecht, Catherine Orrell, Josep Mallolas, Daniel Podzamczer, Benoit Trottier, Wei Zhang, John P. Sabo, Richard Vinisko, Murray Drulak & Anne-Marie Quinson. (2017) Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection. HIV Clinical Trials 18:5-6, pages 189-195.
Read now
Read now
Xiao Li, Ping Gao, Peng Zhan & Xinyong Liu. (2016) Substituted indoles as HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent evaluation (WO2015044928). Expert Opinion on Therapeutic Patents 26:5, pages 629-635.
Read now
Read now
Qing Meng, Na Liu, Boshi Huang, Peng Zhan & Xinyong Liu. (2015) Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419. Expert Opinion on Therapeutic Patents 25:12, pages 1477-1486.
Read now
Read now
Xiao Li, Lingzi Zhang, Ye Tian, Yu’ning Song, Peng Zhan & Xinyong Liu. (2014) Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 24:11, pages 1199-1227.
Read now
Read now
Articles from other publishers (14)
Eriko Ohsaki & Keiji Ueda. (2020) Screening and Evaluation of Novel Compounds against Hepatitis B Virus Polymerase Using Highly Purified Reverse Transcriptase Domain. Viruses 12:8, pages 840.
Crossref
Crossref
Yi Zheng, Radia Aboura, Sana Boujaafar, Gabrielle Lui, Déborah Hirt, Naïm Bouazza, Frantz Foissac, Jean-Marc Treluyer, Sihem Benaboud & Inès Gana. (2020) HPLC-MS/MS method for the simultaneous quantification of dolutegravir, elvitegravir, rilpivirine, darunavir, ritonavir, raltegravir and raltegravir-β-d-glucuronide in human plasma. Journal of Pharmaceutical and Biomedical Analysis 182, pages 113119.
Crossref
Crossref
Pouria Shirvani, Afshin Fassihi & Lotfollah Saghaie. (2018) Recent Advances in the Design and Development of Non‐nucleoside Reverse Transcriptase Inhibitor Scaffolds. ChemMedChem 14:1, pages 52-77.
Crossref
Crossref
Jiangzhou You, Hongren Wang, Xiaojun Huang, Zhen Qin, Zhaomin Deng, Jun Luo, Baoning Wang & Mingyuan Li. (2016) Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials. PLOS ONE 11:8, pages e0160087.
Crossref
Crossref
Xiao Li, Boshi Huang, Zhongxia Zhou, Ping Gao, Christophe Pannecouque, Dirk Daelemans, Erik De Clercq, Peng Zhan & Xinyong Liu. (2016) Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism Approach. Chemical Biology & Drug Design 88:2, pages 241-253.
Crossref
Crossref
Abhijit A. Date, Annemarie Shibata, Patrick Bruck & Christopher J. Destache. (2015) Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates. Biomedical Chromatography 29:5, pages 709-715.
Crossref
Crossref
Prashant R. Nambiar, Daniel Morton, Leland Wayne Dochterman, Christopher Houle, Peter J. Thomford, Gwendolyn Fate, Steven A. Bailey & Gregory L. Finch. (2014) Two-year Carcinogenicity Study in Rats with a Nonnucleoside Reverse Transcriptase Inhibitor. Toxicologic Pathology 43:3, pages 354-365.
Crossref
Crossref
Meizhen Feng, Deping Wang, Jay A. Grobler, Daria J. Hazuda, Michael D. Miller & Ming-Tain Lai. (2015)
In Vitro
Resistance Selection with Doravirine (MK-1439), a Novel Nonnucleoside Reverse Transcriptase Inhibitor with Distinct Mutation Development Pathways
. Antimicrobial Agents and Chemotherapy 59:1, pages 590-598.
Crossref
Crossref
Minghui Dong & Yujie Ren. (2015) Molecular modeling studies of dihydro-alkyloxy-benzyl-oxopyrimidines (DABOs) as non-nucleoside inhibitors of HIV-1 reverse transcriptase using 3D-QSAR, Topomer CoMFA and molecular docking simulations. RSC Advances 5:18, pages 13754-13761.
Crossref
Crossref
Dante Rotili, Domenico Tarantino, Maxim B. Nawrozkij, Alexandre S. Babushkin, Giorgia Botta, Biagina Marrocco, Roberto Cirilli, Sergio Menta, Roger Badia, Emmanuele Crespan, Flavio Ballante, Rino Ragno, José A. Esté, Giovanni Maga & Antonello Mai. (2014)
Exploring the Role of 2-Chloro-6-fluoro Substitution in 2-Alkylthio-6-benzyl-5-alkylpyrimidin-4(3
H
)-ones: Effects in HIV-1-Infected Cells and in HIV-1 Reverse Transcriptase Enzymes
. Journal of Medicinal Chemistry 57:12, pages 5212-5225.
Crossref
Crossref
Michael J. Dapp, Laurent Bonnac, Steven E. Patterson & Louis M. Mansky. (2014) Discovery of Novel Ribonucleoside Analogs with Activity against Human Immunodeficiency Virus Type 1. Journal of Virology 88:1, pages 354-363.
Crossref
Crossref
Guoyi Wu, Bo Liu, Yingjun Zhang, Jing Li, Alla Arzumanyan, Marcia M. Clayton, Raymond F. Schinazi, Zhaohe Wang, Siegfried Goldmann, Qingyun Ren, Faxhou Zhang & Mark A. Feitelson. (2013) Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly. Antimicrobial Agents and Chemotherapy 57:11, pages 5344-5354.
Crossref
Crossref
Devinder Sharma, Aik Jiang Lau, Matthew A. Sherman & Thomas K.H. Chang. (2013) Agonism of human pregnane X receptor by rilpivirine and etravirine: Comparison with first generation non-nucleoside reverse transcriptase inhibitors. Biochemical Pharmacology 85:11, pages 1700-1711.
Crossref
Crossref
Yu’ning Song, Peng Zhan, Dongwei Kang, Xiao Li, Ye Tian, Zhenyu Li, Xuwang Chen, Wenmin Chen, Christophe Pannecouque, Erik De Clercq & Xinyong Liu. (2013) Discovery of novel pyridazinylthioacetamides as potent HIV-1 NNRTIs using a structure-based bioisosterism approach. MedChemComm 4:5, pages 810.
Crossref
Crossref